MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.44	11.69	17.98	24.15	34.11	19.91
Short-Term Investments	-	0.19	0.27	0.76	1.14	2.06
Cash & Short-Term Investments	8.44	11.88	18.25	24.9	35.25	21.97
Cash Growth	-50.86%	-34.92%	-26.73%	-29.36%	60.46%	-44.11%
Accounts Receivable	7.79	6.88	5.52	12.35	15.72	27.72
Other Receivables	-	0.63	0.35	0.66	1.2	6.41
Receivables	7.79	7.51	5.87	13.01	16.92	34.14
Inventory	10.42	8.56	9.89	7.78	10.98	22.14
Prepaid Expenses	-	0.42	0.64	0.69	1.06	0.44
Other Current Assets	5.14	4.71	2	0.98	1.34	2.84
Total Current Assets	31.8	33.08	36.63	47.35	65.55	81.52
Property, Plant & Equipment	18.82	19.16	25.27	18.11	25.89	34.14
Long-Term Investments	-	-	-	-	-	0.19
Other Intangible Assets	0.81	0.85	1.03	0.04	0.04	0.23
Other Long-Term Assets	0.64	0.64	1	-	0.88	2.15
Total Assets	52.07	53.73	63.94	65.5	92.36	118.23
Accounts Payable	8.49	4.24	2.13	3.54	2.99	5.55
Accrued Expenses	0.22	4.49	4.91	3.67	4.14	9.25
Short-Term Debt	0.09	0.26	2.11	0.52	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	7.38
Current Portion of Leases	-	0.08	0.12	0.08	0.11	0.32
Current Unearned Revenue	-	0.61	0.39	0.49	1.32	1
Other Current Liabilities	-	0.83	1.21	1.15	0.31	0.75
Total Current Liabilities	8.8	10.5	10.86	9.46	8.88	24.25
Long-Term Debt	0.03	-	-	-	-	10.54
Long-Term Leases	-	0.05	0.07	0.03	0.1	0.22
Long-Term Unearned Revenue	-	-	-	-	0.23	-
Other Long-Term Liabilities	-	-	-	-	0	4.81
Total Liabilities	8.84	10.55	10.93	9.49	9.22	39.82
Common Stock	201.22	201.21	200.24	191.26	190.55	138.51
Retained Earnings	-187.81	-187.43	-176.73	-163.65	-129.34	-74.54
Comprehensive Income & Other	29.83	29.4	29.49	28.4	21.94	14.45
Total Common Equity	43.23	43.18	53.01	56.01	83.15	78.41
Shareholders' Equity	43.23	43.18	53.01	56.01	83.15	78.41
Total Liabilities & Equity	52.07	53.73	63.94	65.5	92.36	118.23
Total Debt	0.13	0.39	2.3	0.63	0.22	18.46
Net Cash (Debt)	8.32	11.49	15.95	24.27	35.04	3.51
Net Cash Growth	-44.79%	-27.99%	-34.27%	-30.73%	897.86%	-87.78%
Net Cash Per Share	0.02	0.03	0.04	0.09	0.14	0.03
Filing Date Shares Outstanding	415.12	415.14	404.05	282.16	273.94	257.95
Total Common Shares Outstanding	415.12	415.05	401.4	282.16	273.54	155.55
Working Capital	23	22.59	25.77	37.89	56.67	57.28
Book Value Per Share	0.10	0.10	0.13	0.20	0.30	0.50
Tangible Book Value	42.42	42.33	51.97	55.97	83.1	78.19
Tangible Book Value Per Share	0.10	0.10	0.13	0.20	0.30	0.50
Land	-	1.86	2.81	1.52	1.86	1.89
Buildings	-	24.97	27.84	20.93	24.79	25.49
Machinery	-	15.1	18.24	17.46	18.88	18.44
Construction In Progress	-	0.05	2.5	2.6	4.49	3.26
Leasehold Improvements	-	0.21	0.21	0.21	0.21	0.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.